For Bayer, it looks like a victory, but it's a defeat.

It looks like a victory, but it is a defeat: at first glance it seems good news that Judge Vince Chhabria at the District Court in San Francisco reduces the damages Bayer has to pay to the cancer pensioner Edwin Hardeman. Eighty million dollars makes good 25 million. But for Bayer, it's just a consolation.

The German Dax Group, which took over Monsanto, the controversial US agricultural empire last year, had asked for an acquittal, a verdict that exonerates glyphosate from the suspicion of cancer. This would have been good for Bayer, because the Hardeman case was a so -called Bellwether case, a test for many other procedures. Judge Chhabria alone has hundreds of complaints.
Overall, more than 13.400 people are going to trial in the United States against Bayer. So far, the group has been unable to win a case. Clearly, the Germans will not get around to making a comparison. But Bayer is trying to reduce the amount. However, this will only be possible if the group is able to produce judgements that agree with it. Therefore, the Leverkusen people currently have no choice but to appeal.
(徳囯ASK电容器)